drugset
drugset / Trial / NCT04172558

Intracavernous Injection of Botox 100 U for Treatment of PDE5Is Inconvenient Patients With ED

NCT04172558 ↗

Phase 2/3 Unknown 124 enrolled Benha University
RandomizedParallel-groupOpen-labelTreatment

Summary

There is a new emerging concept that Botulinum Toxin Type A may have a potential role in treatment of erectile dysfunction with a longer duration of action. So, the investigators opted to perform this study to compare ICI of Botulinum Toxin Type A versus Trimix for treatment of ED.

Timeline

Start
2019-03-10
Primary completion
2022-10-01
Completion
2022-11-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Botulinum toxin type A Protein / enzyme biologic 100 iu Other
Comparator TriMix Messenger RNA (mRNA) — Other

Indications

erectile dysfunction